Louisiana AG Liz Murrill reached a $45 million settlement with CVS Health Corp. and its pharmacy benefit manager (PBM) subsidiary to resolve three lawsuits alleging deceptive and anti-competitive practices that allegedly violated the Louisiana Unfair Trade Practices Act. According to the AG’s office, the settlement resolves allegations that CVS improperly used customer information to conduct…

Read More

The FTC reached a settlement with Express Scripts, Inc. and its affiliates (collectively “Express Scripts”) to resolve an administrative lawsuit alleging the pharmacy benefit manager violated Section 5 of the FTC Act by artificially inflating insulin prices.

Read More

Iowa AG Brenna Bird filed a lawsuit against multiple pharmacy benefit managers (PBMs) and insulin manufacturers, alleging the companies violated Iowa’s Consumer Fraud Act by artificially inflating diabetes drug prices for Iowa consumers. According to the petition, the PBMs and manufacturers allegedly engaged in an unlawful pricing scheme that substantially increased the price of insulin…

Read More

A coalition of 48 AGs led by Connecticut AG William Tong reached separate settlements with Lannett Company, Inc. (“Lannett”) and Bausch Health US, LLC/Bausch Health Americas, Inc. (“Bausch”) in generic-drug antitrust litigation. The states allege the companies participated in long-running conspiracies to fix prices and otherwise restrain competition in the generic drug market, including through…

Read More

In this column for Law360, Chuck Slemp analyzes how a Virginia investigation into insulin manufacturers and pharmacy benefit managers reflects a broader national trend of state AGs targeting drug pricing practices using consumer protection and antitrust laws to tackle opaque pricing structures and drive healthcare affordability.

Read More